Yunhu Technology Secures Tens of Millions in USD in Series A+ Funding, Projects Annual Revenue of RMB 3 Billion

Recently, VCBeat learned that Yunhu Technology, a leading enterprise in the internet service platform for primary healthcare industry, has completed tens of millions of dollars in Series A+ financing.

This round of financing was led by Creation Ventures Capital (CCV), with participation from existing shareholders Yuanjing Capital, Morningside Venture Capital, CAS Star, and Boyuan Capital. China Renaissance Alpha served as the exclusive financial advisor for this round.

Since 2014, projects in the primary healthcare sector have gradually attracted capital interest; however, as most of these ventures have yet to identify a viable path to profitability, investors have grown increasingly cautious about such opportunities over the past year.

Even under these circumstances, Yunhu Technology has largely kept its fundraising frequency to once every few months since its inception in 2017. Why has it been able to secure funding repeatedly? What are its plans following this latest round of financing?

Chen Xiaobing, founder and CEO of Yunhu Technology, told VCBeat that after this round of financing, the company will mainly focus on three things:

First, focus on accelerating market expansion, product development, and sales team building; advance the informatization of primary healthcare institutions and empower them to ensure the practical implementation of smart clinic solutions at the grassroots level.

Second, Yunhu Technology will integrate the entire patient journey at the primary care level, covering triage and consultation, diagnostic testing, pharmaceutical and medical device delivery, rehabilitation therapy, post-consultation follow-up, and health insurance payment. This end-to-end integration enables primary healthcare institutions to deliver more professional services to patients more effectively.

Third, by fully leveraging the seamless integration of the platform’s online and offline operational service systems to deeply engage C-end patients, there is immense potential for future growth.

Yunhu Technology has long been committed to following the national “tiered diagnosis and treatment” policy, guided by the needs of primary healthcare institutions and patients. It empowers primary healthcare institutions to enhance their operational efficiency, management capabilities, diagnostic accuracy, and service quality. By building a network of primary healthcare services and a comprehensive product matrix, Yunhu Technology promotes the decentralization of medical technology and resources to lower-tier cities, reduces healthcare costs for the general public, and enables residents to access high-quality, convenient basic medical services comparable to those in first-tier cities right at their doorstep.

Chen Xiaobing stated that after two years of operational development, Yunhu Technology now has a total workforce of over 800 employees. Its business services have expanded to 16 provinces and four municipalities directly under the Central Government, serving more than 50,000 primary healthcare institutions and millions of primary care patients. The company has received widespread acclaim, with its monthly revenue exceeding RMB 15 million.The growth rate has remained around 30% in recent months, with projected annual revenue reaching RMB 300 million.

Among Yunhu Technology’s clients, how many are private primary healthcare institutions, and how many are public primary healthcare institutions?

“Currently, approximately 67% of our clients are private medical institutions, such as clinics, while 33% are public medical institutions, including community health service centers. In terms of service categories, Yunhu Technology offers different solutions for private and public medical institutions. For clinics, we primarily provide services such as laboratory testing and training,” Chen Xiaobin admitted.

Meanwhile, he also hopes that Yunhu Technology will cover 150,000 primary healthcare institutions this year, with revenue exceeding RMB 300 million, and serve 300,000 institutions by 2020. How can this be achieved?

In Chen Xiaobing’s view, Yunhu Technology’s down-to-earth approach over the past two years has helped accumulate a substantial user base and build a strong reputation. This positions the company well for doubling its business volume and customer count in the future. Primary healthcare institutions operate within close-knit networks; once our services gain acceptance and recognition from one institution, awareness spreads rapidly like a snowball effect. Coupled with current capital support, this momentum will further enable our team to quickly penetrate the market.

Furthermore, Yunhu Technology integrates third-party medical laboratories with self-built and co-established physician-affiliated laboratories, linking clinic-side SaaS software with the cloud-based Yunhu Medical APP for service providers. By implementing cloud-managed cold-chain logistics for specimen transport, it has formed a secure, efficient, and high-quality closed-loop system for primary care medical testing services. Its “one-stop primary care medical testing service” pioneers rapid testing at the grassroots level through a model combining 24-hour routine testing, 2-hour rapid testing, last-mile cold-chain logistics, and cloud-based test reports, achieving the highest operational efficiency in China.

More importantly, the team operates with high efficiency. Chen Xiaobin explained that after capturing a city, he would leave three people to continue serving the local market, while the rest would move on to capture the next city. This approach maximizes talent allocation and conserves human resources.

He broke down the numbers for us: with three staff members per city and Yunhu Technology’s clients now spanning over 300 cities, this alone amounts to more than 900 marketing personnel. This represents the leanest staffing configuration; in cities where the market is less mature, five to six people may be required. Teams are then further tailored based on customer density and effective conversion rates.

Regarding this investment, Zhou Wei, Managing Partner of CCV (Creation & Venture Capital), stated, “The uneven distribution of medical service resources has long been a significant challenge. At CCV, our investments at the intersection of healthcare and technology aim to address this issue from technological and networking perspectives. Yunhu Technology is committed to building an extensive technology and service network to empower small and micro medical institutions, enabling them to provide more basic medical services and keep patients within their local communities for treatment. In the future, Yunhu’s network is well-positioned to offer additional value-added services to these small and micro medical institutions. We believe that Yunhu’s platform will play a substantial role in effectively supporting a growing number of small and micro medical institutions with medical resources.”

Zhou Xiang, Managing Director at China Renaissance and Head of Huaxing Alpha, stated, “Since its establishment, Yunhu Technology has remained committed to serving grassroots medical institutions. Guided by patient needs, the company empowers these institutions through its team’s exceptional operational efficiency, management capabilities, and service standards, thereby helping to balance the distribution of medical resources. As a result, it has quickly emerged as an industry leader. Huaxing Alpha is honored to have assisted the company in completing this round of financing. We are confident that, following this investment, Yunhu Technology will further refine and strengthen its product portfolio and team building, gradually developing into China’s largest primary care service platform.”